Pressure-controlled intermittent coronary sinus occlusion (PiCSO) therapy added to primary PCI does not seem to reduce myocardial infarct size in patients with anterior ST-segment elevation myocardial ...

BOSTON, MA—Patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and elevated left atrial pressures appear to derive lasting benefits from a shunt that diverts ...

The coronary sinus (CS) refers to a collection of veins that join together to form a large blood vessel. This vein is located between the left atrium and the left ventricle of the heart. A collection ...

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling ...